Coccinia grandis: Phytochemical Diversity, Molecular Pharmacological Insights and Emerging Nano-Formulations

Abstract

Coccinia grandis, also known as the ivy gourd, is a popular medicinal plant used in traditional medical systems in Asia and Africa. This paper summarises its diverse phytochemical makeup and medicinal potential. The plant contains several bioactive compounds including flavonoids, terpenoids, and phenolics, which contribute to its anti-diabetic, antioxidant, anti-inflammatory, hepatoprotective, antibacterial, and neuroprotective properties. Research shows that it can influence important metabolic enzymes, reduce oxidative stress, promote tissue repair, and regulate inflammatory pathways. Emerging data also suggest possible anticancer, anti-obesity, and anti-arthritic benefits, mostly through mechanisms involving enzyme inhibition and regulation of immunological signalling. Furthermore, recent advances in the manufacturing of green nanoparticles from C. grandis extracts have demonstrated improved antibacterial, catalytic, and therapeutic properties. Overall, Coccinia grandis is a rich natural resource with important pharmacological applications and an increasing promise for future drug development and nanomedicine.